Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C Full Text
Chinese Medical Journal, 06/12/2012
Ying–ying Z et al. – Among patients with hepatitis C virus genotype 1, the elderly patients had lower sustained virological response than non–elderly patients during pegylated interferon–alpha–2a plus ribavirin combination therapy.



